▶ 調査レポート

GMP試験サービスの世界市場:成長・動向・市場規模予測(2020-2025)

• 英文タイトル:GMP Testing Service Market - Growth, Trends, and Forecast (2020 - 2025)

Mordor Intelligenceが調査・発行した産業分析レポートです。GMP試験サービスの世界市場:成長・動向・市場規模予測(2020-2025) / GMP Testing Service Market - Growth, Trends, and Forecast (2020 - 2025) / D0-MOR-AP0620資料のイメージです。• レポートコード:D0-MOR-AP0620
• 出版社/出版日:Mordor Intelligence / 2020年4月20日
• レポート形態:英文、PDF、117ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:健康管理
• 販売価格(消費税別)
  Single User¥629,000 (USD4,250)▷ お問い合わせ
  Team User¥703,000 (USD4,750)▷ お問い合わせ
  Corporate License¥1,110,000 (USD7,500)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートは、GMP試験サービスの世界市場について調査・分析した資料で、GMP試験サービスの市場概要、動向、セグメント別市場規模、地域別分析、競争状況、企業情報、市場機会分析などで構成されています。

The GMP Testing Service Market is expected to register a CAGR of 6.5% during the forecast period due to the growing pharmaceutical industry and the increasing need for developing novel devices and drugs. According to the European Federation of Pharmaceutical Industries and Associations, the overall sales of the pharmaceutical industry worldwide were recorded to be approximately 852,647 million USD in 2017. Furthermore, according to the International Journal of Environmental Research and Public Health’s published study, around 40 medications are recalled per year in the United States and South Korea. This emerges the need for testing the products and the manufacturing process. Furthermore, outsourcing these services enables companies to reduce capital investments. Hence, these factors are expected to play a major role in the GMP testing services market growth. However, the precise requirement of the regulatory framework with respect to GMP outsourced activities may hinder the market growth.
Key Market Trends

Pharmaceutical and Biopharmaceutical Companies Segment is Expected to Hold a Major Market Share in the GMP Testing Service Market

– The novel drug development in the pharmaceutical and biopharmaceutical industry is expected to drive the market growth in this segment. According to the study published by the Journal of Industrial Microbiology & Biotechnology, almost 300 biopharmaceuticals have been patented in the last three decades and the economic output of the biopharmaceutical industry was accounted to be 1.3 trillion USD in 2015, according to the International Trade Administration. This demands more quality and safety management of products which is expected to increase the demand for GMP testing services.
– Moreover, according to the US FDA (Food & Drug Administration) list of GMP facilities, there are around 3,652 facilities related to packaging, analytical testing, etc. in 36 countries. Approximately 2,515 facilities in the list were accounted for API production facilities and finished dosage form facilitiesThus, the pharmaceutical and biopharmaceutical companies segment is expected to impact positively on the GMP testing services market growth.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to be a dominant region in the GMP testing services market due to the emerging need for developing new drugs and devices. According to the Centre for Disease Control and Prevention, around 3.5 trillion USD of the amount is spent on chronic diseases in the United States. According to the same source, around 859,000 people die due to heart stroke in the United States. Also, the number of increasing drug manufacturing plants is expected to drive the GMP testing services market growth. According to the United States Food & Drug Administration (FDA), the United States had approximately 4,676 manufacturing sites for drugsHence, these factor demands developing new drugs and thereby expected to boost the demand for GMP testing services market growth.

Competitive Landscape

The GMP Testing Service Market consists of several major players. In terms of market share, few of the major players are currently dominating the market. Furthermore, the companies are taking initiatives to meet the larger demand of medicines and devices. For instance, PPD, Inc., in 2018 set up a new plant facility dedicated to testing of biologics. Some of the companies which are currently dominating the market are Eurofins Scientific, PPD, Inc., Microchem Laboratory, Sartorius AG, NORTH AMERICAN SCIENCE ASSOCIATES INC., Covance, Inc., Nelson Laboratories, LLC, Almac Group, Pace Analytical and Wuxi AppTec.

Reasons to Purchase this report:

– The market estimate (ME) sheet in Excel format
– 3 months of analyst support

レポート目次

1 INTRODUCTION
1.1 Study Assumptions
1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Pharmaceutical Industry
4.2.2 Increasing Drug and Devices Development
4.3 Market Restraints
4.3.1 Stringent Regulatory Framework
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION
5.1 By Service Type
5.1.1 Product Validation Testing
5.1.2 Bioanalytical Services
5.1.3 Packaging and Shelf-Life Testing
5.1.4 Others
5.2 By End User
5.2.1 Pharmaceutical & Biopharmaceutical Companies
5.2.2 Medical Devices Company
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Rest of the World

6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Eurofins Scientific
6.1.2 PPD, Inc.
6.1.3 Microchem Laboratory
6.1.4 Sartorius AG
6.1.5 NORTH AMERICAN SCIENCE ASSOCIATES INC.
6.1.6 Covance, Inc.
6.1.7 Nelson Laboratories, LLC
6.1.8 Almac Group
6.1.9 Pace Analytical
6.1.10 Wuxi AppTec

7 MARKET OPPORTUNITIES AND FUTURE TRENDS